Rite Aid (RAD) Sept. Sames Store Sales Increase 1.5%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St futures drop as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- Oil gains over 3% as US-Iran peace talks in stalemate
- Stock action shows confidence in central banks: BofA’s Hartnett
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Rite-Aid's (RAD) Buy Rating Maintained at Deutsche Bank
October 1, 2015 3:33 PM EDTDeutsche Bank maintained a Buy rating on Rite-Aid (NYSE: RAD) with a price target of $9. Earlier Rite-Aid reported September comps increased 1.5%. In the view of analyst George Hill, soft script trends were not a surprise.
"Prescription count at comparable stores for the month decreased -0.7%. Pharmacy same store sales for September grew +2.2%, incorporating a -234 bps impact from new generic drug introductions.... More
